IDP.L Regulatory News (IDP)

13 October 2017

InnovaDerma plc

Admission of Shares

InnovaDerma plc ("InnovaDerma", the "Company" or, together with its subsidiary undertakings, the "Group") announces that, due to an oversight, application was not made for 821,335 ordinary shares of €0.10 each ("Ordinary Shares") in the capital of the Company to be admitted to trading or for admission to the Official List. These shares are already in issue and thus were included in the total voting rights disclosure of 9 October.

Application has now been made for these shares to be admitted to trading and to the Official List and it is expected that admission will be effective on or around 17 October 2017 ("Admission").

Following Admission the Company will, as announced on 9 October, have a total of 14,265,571 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules of the FCA.

Further enquiries:

About InnovaDerma:

InnovaDerma PLC (LSE: IDP) specialises in the research, manufacture and marketing of clinically proven products in life sciences, beauty and personal care products. InnovaDerma has presence in Europe, US, Australasia, Asia and Africa.